Small Molecule : Kinase Inhibitors. ^{(122 Preclinical Stage Companies)}

Small Molecule : Proteolysis Targeting Chimera (PROTACs). ^{(29 Preclinical Stage Companies)}

Small Molecule : RNA Targeting Therapeutics. ^{(43 Preclinical Stage Companies)}

Nanoparticles/Nanotechnology based Cancer Targeting Drugs. ^{(61 Preclinical Stage Companies)}

Cellular Therapy: T Cell/CAR-T/CAR-NK & other Cell based Therapies. ^{(125 Preclinical Stage Companies)}

Oncolytic Viruses pipeline in Early Stage Development. ^{(35 Preclinical Stage Companies)}

Monoclonal Antibodies pipeline in Early Stage Development. ^{(162 Preclinical Stage Companies)}

Bi-Specific & Multi Specific Antibodies pipeline in Early Stage Development.^{(66 Preclinical Stage Companies)}

Antibody Drug Conjugates pipeline in Early Stage Development. ^{(62 Preclinical Stage Companies)}

Cancer Vaccines pipeline in Early Stage Development. ^{(80 Preclinical Stage Companies)}

Exosome & Microvesicles based Cancer Targeting Drugs. ^{(17 Preclinical Stage Companies)}

Microbiome based Cancer Targeting Drugs. ^{(15 Preclinical Stage Companies)}